semaglutide flow trial kidney outcomes 2024 nejm hazard ratio Long-term of in obesity and cardiovascular disease in the SELECT Effects of semaglutide with and – Semaglutide in patients with overweight – flow trial semaglutide ppt 🚨

The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe

La supplementazione con L-Carnitina risulterebbe fondamentale anche nei pazienti con deficit primario e secondario di Carnitina, oltre che nei pazienti affetti da patologie neurodegenerative (migliore in quest'ultimo caso risulterebbe l'uso di Acetil-L-Carnitina )

Ghabril 6 , Paul H

This loss of muscle can lower your metabolic rate and make it harder to keep the weight off

McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE